展望2018，生物制药市场发展有多大？
生物制药的发展空间到底有多大？笔者从一些生物制药企业去年的财报以及一些专家、行业人士分析的未来态势，和大家一起分享。
先来看看生物制药企业2017年的表现。强生药品总销售额突破360亿美元大关，其中，肿瘤组合功不可没，多发性骨髓瘤药物和血液癌症药物也被证明对组合业务的增长起到了至关重要的作用。礼来公司表现平稳，虽然其在神经科学领域以及肿瘤学领域有所投资，但其还是主攻糖尿病。礼来方面也希望新的药物能帮助其抵消赖脯胰岛素的萎靡不振。
默克公司在过去一年的表现也不俗，旗下产品帮助默克领跑癌症免疫治疗市场，助力其在一线肺癌方面形成了较强的竞争优势，刺激了销售额的快速增长。另外，笔者获悉，罗氏准备从欧洲扩展到美国，新药是计划的关键。
由此看来，2017年生物制药龙头企业表现各有千秋，2018年的竞争大战也逐渐拉开帷幕。为了做好全面规划，生物制药企业需要了解行业今年的发展趋势。那么，对于生物制药企业来说，2018年有哪些趋势不容错过呢?
1.2018年有望成为全球生物制药并购大年
具体来看，2018年生物制药并购交易会呈现上升趋势，虽然很有可能是因为2017年交易量太低，但是任何增长都将增加2018年的生物制药行业的并购成绩。而随着鼓励社会资本参与医疗体制改革、“健康中国”概念等政策驱动国内并购的活跃，我国药企海外并购的速度也在加快。业内预测，海外并购将会被更多的中国药企纳入发展战略。
2.生物工艺趋势正影响工艺终端用户的技术要求和购买模式
生物制药行业一路高歌，但相关工艺却不能完全满足行业需求。而随着生物工艺趋势对工艺终端用户技术要求和购买模式的影响，以及工艺创新的减缓，生物药企其实承受着巨大的压力。为了直面当前形势，做出实际成效，一些有实力的龙头药企开始建立以客户为中心的协作式研发新产品方法，中小型企业也可以着手创新，通过合作的方式改变现状。
3.许多大型药企正将目光瞄准亚洲市场
亚洲人口数多，消费需求多，尤其是中国。目前，中国已经成为第二大医药消费市场，并占据世界医疗市场四分之一的份额，不少大型药企，例如赛默飞、默克、强生等也都对中国市场较为重视。而为了把握中国市场，各大生物制药企业都在努力维持研发投入，通过创新驱动提高产品生产力。
4.全球竞争始终是一个趋势2018年将继续遵循
哪里有市场，哪里就有竞争，对于生物制药这块肥肉，“战场”已不仅仅局限于一块地方，而是全球。另据有关调查，今年生物制药领域的一个重要趋势就是，提高生产效率以满足不断增长的需求，降低成本以提高产品的总体质量。
Previous: No information found
{"weixin":{"label":"微信","name":"weixin","selected":true,"value":false,"sortid":"1","shareid":"weixin","sharetitle":"分享到微信","event":"shareToWeiXin","lang":"shareWeb_WeiXin"},"copy":{"label":"复制网址","name":"copy","selected":true,"value":false,"sortid":"2","shareid":"copy","sharetitle":"复制网址","event":"copy_url","lang":"shareWeb_Copy"},"qq":{"label":"QQ好友","name":"qq","selected":true,"value":false,"sortid":"2","shareid":"qq","sharetitle":"分享到QQ","event":"shareToQQ","lang":"shareWeb_QQ"},"sina_weibo":{"label":"新浪微博","name":"sina_weibo","selected":true,"value":false,"sortid":"4","shareid":"sina_weibo","sharetitle":"分享到新浪微博","event":"shareToSinaWB","lang":"shareWeb_SinaWeiBo"},"qq_zone":{"label":"QQ空间","name":"qq_zone","selected":true,"value":false,"sortid":"5","shareid":"qq_zone","sharetitle":"分享到QQ空间","event":"shareToQzone","lang":"shareWeb_QQZone"},"renren":{"label":"人人网","name":"renren","selected":true,"value":false,"sortid":"7","shareid":"renren","sharetitle":"分享到人人网","event":"shareToRenren","lang":"shareWeb_RenRen"},"douban":{"label":"豆瓣网","name":"douban","selected":true,"value":false,"sortid":"8","shareid":"douban","sharetitle":"分享到豆瓣网","event":"shareToDouban","lang":"shareWeb_DouBan"},"baidu_tieba":{"label":"百度贴吧","name":"baidu_tieba","selected":true,"value":false,"sortid":"10","shareid":"baidu_tieba","sharetitle":"分享到百度贴吧","event":"shareToTieba","lang":"shareWeb_TieBa"},"Facebook":{"label":"Facebook","name":"Facebook","selected":true,"value":true,"sortid":"11","shareid":"Facebook","sharetitle":"分享到FaceBook","event":"shareToFacebook","lang":"shareWeb_Facebook"},"Twitter":{"label":"Twitter","name":"Twitter","selected":true,"value":true,"sortid":"12","shareid":"Twitter","sharetitle":"分享到Twitter","event":"shareToTwitter","lang":"shareWeb_Twitter"},"LinkedIn":{"label":"LinkedIn","name":"LinkedIn","selected":true,"value":true,"sortid":"13","shareid":"LinkedIn","sharetitle":"分享到linkedIn","event":"shareToLinkedin","lang":"shareWeb_Linkedin"},"whatsapp":{"label":"whatsapp","name":"whatsapp","selected":true,"value":true,"sortid":"15","shareid":"whatsapp","sharetitle":"分享到whatsapp","event":"shareToWhatsapp","lang":"shareWeb_whatsapp"},"line":{"label":"line","name":"line","selected":true,"value":true,"sortid":"15","shareid":"line","sharetitle":"分享到line","event":"shareToLine","lang":"shareWeb_line"},"qq_weibo":{"label":"腾讯微博","name":"qq_weibo","selected":true,"value":true,"sortid":"3","shareid":"qq_weibo","sharetitle":"分享到腾讯微博","event":"shareToQQwb","lang":"shareWeb_QQWeiBo"},"peopleBlog":{"label":"人民微博","name":"propleBlog","selected":true,"value":true,"sortid":"14","shareid":"propleBlog","sharetitle":"分享到人民微博","event":"shareToPeopleBlog","lang":"shareWeb_peopleBlog"}}
